VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependence
- PMID: 30983500
- PMCID: PMC6566135
- DOI: 10.2217/pgs-2018-0137
VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependence
Abstract
Aim: To determine if selected serotonergic and noradrenergic gene variants are associated with heroin addiction. Subjects & methods: A total of 126 variants in 19 genes in subjects with Dutch European ancestry from The Netherlands. Subjects included 281 opioid-dependent volunteers in methadone maintenance or heroin-assisted treatment, 163 opioid-exposed but not opioid-dependent volunteers who have been using illicit opioids but never became opioid-dependent and 153 healthy controls. Results: Nominal associations were indicated for 20 variants in six genes including an experiment-wise significant association from the combined effect of three SLC18A2 SNPs (rs363332, rs363334 and rs363338) with heroin dependence (pfinal = 0.047). Conclusion: Further studies are warranted to confirm and elucidate the role of these variants in the vulnerability to opioid addiction.
Keywords: VMAT2; association study; case–control; exposed but not dependent; heroin dependence.
Conflict of interest statement
This study was supported by grants from the Dr Miriam and Sheldon G Adelson Medical Research Foundation (MJK), a special supplement to National Institutes of Health grant R01-DA012848 (MJK) and a grant from The Netherlands Ministry of Health, Welfare and Sports. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of thismanuscript.
Figures

References
-
- Kreek MJ, Bart G, Lilly C, Laforge KS, Nielsen DA. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol. Rev. 2005;57(1):1–26. - PubMed
-
- Kreek MJ, Laforge KS. Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene. Mol. Interv. 2007;7(2):74–78. - PubMed
-
- Kreek MJ, Nielsen DA, Butelman ER, Laforge KS. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat. Neurosci. 2005;8(11):1450–1457. - PubMed
-
- Proudnikov D, Laforge KS, Hofflich H, et al. Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypes. Pharmacogenet. Genomics. 2006;16(1):25–36. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical